Search results
Results From The WOW.Com Content Network
In December 2014, Labcorp acquired Bode Technology Group, a provider of forensic DNA analysis, DNA collection products, and relationship testing and the largest DNA forensic testing company in the U.S., from SolutionPoint International. [49] [50] [51] In February 2015, Labcorp acquired Covance for $6.1 billion. [52] [53]
In February 2015, Labcorp acquired Covance for $6.1 billion in cash and stock. [37] [38] In 2016, the company entered into a strategic alliance with Global Specimen Solutions, in which the company offered GSS products GlobalCODE and snapTRACK to its clients. [39] In December 2017, Covance acquired the company. [40]
The companies are discussing a deal in which part of LabCorp's Covance clinical research division would merge with Syneos. The sources said that the companies are discussing structuring the deal ...
LabCorp's (LH) Covance arm grows on strategic acquisitions including MI Bioresearch.
April 1999: Covance (now Fortea) announced it would acquire Parexel for $612.7 million in stock; [20] however, the agreement was terminated two months later. [21] September 1999: Parexel acquires CEMAF S.A., a Phase I clinical research and bioanalytical laboratory located in Poitiers, France for an initial cash payment of approximately $3.0 ...
LabCorp (LH) expands service portfolio through Covance's data management portal. Skip to main content. Sign in. Mail. 24/7 Help. For premium support please call: 800-290-4726 ...
In 2010, the company, which at the time was traded on NASDAQ as VTIV, went private with the acquisition by Thomas H. Lee Partners in a deal estimated at $1.1 billion. [13] [14] In January 2018, eight months after INC Research announced plans to acquire it, [15] the firm assumed a new name, Syneos Health, and stock symbol, Nasdaq: SYNH. [16]
Within Covance Drug Development, LabCorp (LH) is expected to drive profitable growth through expanded solutions and enhanced operational capabilities.